Gain in US prostate cancer sales disappoints Telix investors
MELBOURNE: ASX-listed biotech Telix Pharmaceuticals has reported a near 40 per cent sales ... read more
Sonic and Proteomics edge closer to major medical breakthrough
MELBOURNE: Australian life sciences company Proteomics has extended its agreement with pathology giant ... read more
Shares in Recce Pharmaceuticals lift after Australian patent granted
PERTH: Shares in Perth-founded Recce Pharmaceuticals have lifted after the company announced it ... read more
Neuren tops health stocks list with gain of 100+ per cent
MELBOURNE: Neuren’s focus on rare neurological conditions in children instead of targeting higher-profile ... read more
